Development of Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk

BACKGROUND: Breast cancer (BC) risk assessment models are statistical estimates based on patient characteristics. We developed a gene expression assay to assess BC risk using benign breast biopsy tissue. STUDY DESIGN: A NanoString-based Malignancy-Risk (MR) gene signature was validated for formalin-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Surg Res
Hauptverfasser: Sun, James, Chen, Dung-Tsa, Li, Jiannong, Sun, Weihong, Yoder, Sean J., Mesa, Tania E., Wloch, Marek, Roetzheim, Richard, Laronga, Christine, Lee, M. Catherine
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900446/
https://ncbi.nlm.nih.gov/pubmed/31419640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2019.07.021
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge